CMS certification 370028
Integris Baptist Medical Center, INC
3300 Northwest Expressway, Oklahoma City, OK 73112
Integris Baptist Medical Center has a CMS overall rating of 3 out of 5 stars. 73% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 5 and worse on 2. Emergency patients spend a median of 2 h 28 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 2,285 completed surveys, 18% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | OK | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 396 visits sampled · US median for EDs of the same volume: 3 h 21 min | 2 h 28 min | 1 h 57 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 15 visits sampled | 2 h 31 min | 2 h 54 min | 4 h 17 min |
| Left before being seen Lower is better · 84,954 patients | 3% | 2% | 2% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 128 patients | 48% | 61% | 65% |
How Integris Baptist Medical Center compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Integris Baptist Medical Center, INCThis hospital | 3/5 | 73% | 2 h 28 min | 5 better 2 worse |
| McBride Orthopedic HospitalSame city | Not rated | 86% | 57 min | 1 better 1 worse |
| Onecore HealthSame city | Not rated | 81% | — | No different |
| Integris Southwest Medical CenterSame city | 2/5 | 65% | 1 h 35 min | 4 better |
| Lakeside Women's Hospital, a Member of Integris HeSame city | Not rated | 79% | — | No different |
| Mercy Hospital Oklahoma City, INCSame city | 4/5 | 79% | 2 h 31 min | 4 better |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Oklahoma City.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 5,678 cases | Too few cases | 4.3% | 3.9% |
| Heart attack 199 cases | Too few cases | 14.4% | 11.9% |
| Heart failure 561 cases | Too few cases | 12.2% | 11.1% |
| Pneumonia 706 cases | Too few cases | 11.9% | 15.2% |
| Stroke 622 cases | Too few cases | 12.1% | 11.9% |
| COPD 233 cases | Too few cases | 10.1% | 8.6% |
| Heart bypass surgery (CABG) 122 cases | Too few cases | 3.2% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 0.84 likely 0.63 – 1.05 | 1 |
| After hip or knee replacement 39 cases | Too few cases | 3.6% | 4.1% |
| Deaths after a serious but treatable surgical complication 272 cases | No different | 188.97 per 1,000 likely 151.93 per 1,000 – 226.01 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 9,877 cases | No different | 0.23 per 1,000 likely 0 per 1,000 – 0.68 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 11,917 cases | No different | 0.19 per 1,000 likely 0.02 per 1,000 – 0.37 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 12,739 cases | No different | 0.27 per 1,000 likely 0.09 per 1,000 – 0.44 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 3,581 cases | No different | 1.79 per 1,000 likely 0.68 per 1,000 – 2.9 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 1,571 cases | No different | 2.27 per 1,000 likely 1.05 per 1,000 – 3.48 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 1,595 cases | No different | 11.28 per 1,000 likely 7.42 per 1,000 – 15.13 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 3,915 cases | No different | 2.49 per 1,000 likely 0.93 per 1,000 – 4.05 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 1,573 cases | No different | 3.98 per 1,000 likely 1.38 per 1,000 – 6.57 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 954 cases | No different | 1.55 per 1,000 likely 0.24 per 1,000 – 2.87 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 3,084 cases | No different | 0.7 per 1,000 likely 0 per 1,000 – 1.48 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | Better | 0.38 likely 0.21 – 0.63 | 1 |
| Urinary tract infections from catheters (CAUTI) | Better | 0.32 likely 0.16 – 0.59 | 1 |
| Surgical site infections after colon surgery | No different | 0.96 likely 0.55 – 1.57 | 1 |
| Surgical site infections after abdominal hysterectomy | No different | 1.35 likely 0.34 – 3.66 | 1 |
| MRSA bloodstream infections | No different | 1.36 likely 0.86 – 2.07 | 1 |
| C. diff intestinal infections | Better | 0.33 likely 0.24 – 0.43 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 280 cases | Too few cases | 15% | 14.4% |
| Readmitted after heart failure 871 cases | Too few cases | 21% | 21.3% |
| Readmitted after pneumonia 976 cases | Too few cases | 17.1% | 17.3% |
| Readmitted after COPD 399 cases | Too few cases | 20.2% | 20% |
| Readmitted after heart bypass surgery 79 cases | Too few cases | 10.3% | 11% |
| Readmitted after hip or knee replacement 43 cases | Too few cases | 7% | 5.8% |
| Days back in hospital after a heart attack 269 cases | Too few cases | 11.7 days per 100 | — |
| Days back in hospital after heart failure 700 cases | Too few cases | -9.4 days per 100 | — |
| Days back in hospital after pneumonia 780 cases | Too few cases | -0.2 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 1,911 cases | No different | 15.3 per 1,000 likely 12.2 per 1,000 – 19.2 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 449 cases | No different | 9.1 per 100 likely 7.2 per 100 – 11.3 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 449 cases | Worse | 7.7 per 100 likely 6 per 100 – 9.7 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 1,688 cases | No different | 1.1 likely 0.9 – 1.2 | — |
1 more measure had too few cases here to report.
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $411,792
- 2020 $733,545
- 2021 $257,842
- 2022 $221,489
- 2023 $560,939
- 2024 $550,786
- 2025 $738,236
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Debt forgiveness | $66,971 | 4 |
| Medical devices and supplies on long-term loan | $26,148 | 8 |
| Speaking, teaching and other services | $9,000 | 2 |
| Education | $560 | 1 |
| Food and beverage | $148 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Merck Sharp & Dohme LLC | $441,797 | 2 |
| United Therapeutics Corporation | $143,153 | 30 |
| Stryker Corporation | $78,433 | 9 |
| Janssen Research & Development, LLC | $21,265 | 13 |
| Exelixis Inc. | $15,474 | 2 |
| AngioDynamics, Inc. | $13,000 | 1 |
| Canon Medical Systems USA, Inc. | $9,000 | 2 |
| AstraZeneca UK Limited | $4,825 | 1 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| An Open-Label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Background Pulmonary Arterial Hypertension PAH Therapy f… Merck Sharp & Dohme LLC | $323,216 |
| A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY… United Therapeutics Corporation · NCT05203510 | $143,153 |
| A Phase 3, Randomized Double-blind, Placebo-controlled Study to Evaluate Sotatercept When Added to Background Pulmonary Arterial Hypertension PAH The… Merck Sharp & Dohme LLC | $118,580 |
| A Phase 3 Prospective Multi Center Double blind Double dummy Randomized Active controlled Parallel Group sequential Adaptive Event driven Study to Co… Janssen Research & Development, LLC | $21,265 |
| A Randomized Open-Label Phase 3 Study of XL092 + Atezolizumab vs Regorafenib in Subjects with Metastatic Colorectal Cancer Exelixis Inc. | $15,474 |
| A Phase IIIb, Single Arm, Open-label, Multicentre Study of Durvalumab in Combination with Chemotherapy for the First Line Treatment for Patients with… AstraZeneca UK Limited | $4,825 |
| A Prospective Randomized Single Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 Drug Eluting Balloon in the Tr… M.A. Med Alliance S.A. | $4,020 |
| realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLB… Incyte Corporation | $3,175 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Integris Baptist Medical Center
Is Integris Baptist Medical Center a good hospital?
Integris Baptist Medical Center has a CMS overall rating of 3 out of 5 stars. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 5 and worse on 2. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Integris Baptist Medical Center?
73% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 2,285 completed HCAHPS surveys.
How long is the wait in the Integris Baptist Medical Center emergency room?
Emergency patients spend a median of 2 h 28 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 3% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Integris Baptist Medical Center receive money from drug and device companies?
Drug and device makers reported $738,236 in payments to Integris Baptist Medical Center for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.